Ruth Devenyns
Algemeen Directeur bij Precirix NV
Oorsprong van het eerstegraads netwerk van Ruth Devenyns
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland.
19
| Subsidiary | Medical Specialties | 19 |
Ghent University
18
| College/University | Other Consumer Services | 18 |
KBC Private Equity NV
 KBC Private Equity NV Investment ManagersFinance KBC Private Equity is a private equity firm, a subsidiary of KBC Group founded in 1999. The firm is headquartered in Brussels.
17
| Extinct | Investment Managers | 17 |
Precirix NV
 Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Korys Management NV
 Korys Management NV Investment ManagersFinance Korys Management NV is a Private Equity/Venture Capital firm, a subsidiary of Korys NV founded in 2000. Korys Management NV is headquartered in Halle.
9
| Subsidiary | Investment Managers | 9 |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen.
8
| Private Company | Miscellaneous Commercial Services | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ruth Devenyns via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| TIGENIX NV | Medical Specialties | Director/Board Member Founder | |
| GALAPAGOS NV | Biotechnology | Chairman Founder | |
| MDXHEALTH SA | Medical Specialties | Director/Board Member Director/Board Member Chairman | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Director/Board Member Founder Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| QUEST FOR GROWTH NV | Investment Managers | Director/Board Member Director/Board Member | |
| Maastricht University | College/University | Doctorate Degree Graduate Degree | |
KBC Securities NV
 KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors. | Investment Banks/Brokers | President Corporate Officer/Principal | |
Participatiemaatschappij Vlaanderen NV
 Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor General Counsel Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| University of Wisconsin | College/University | Masters Business Admin Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
CropDesign NV
 CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
| ABLYNX | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| TELENET GROUP HOLDING NV | Major Telecommunications | Director of Finance/CFO Director/Board Member | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
| Université Libre de Bruxelles | College/University | Doctorate Degree Graduate Degree | |
| 2VALORISE | Alternative Power Generation | Director/Board Member Chief Executive Officer Director/Board Member | |
| Vlerick Leuven Gent Management School | College/University | Graduate Degree Corporate Officer/Principal Masters Business Admin Undergraduate Degree Masters Business Admin | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Director/Board Member Corporate Officer/Principal | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman | |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
FORMAC Pharmaceuticals NV
 FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Applied Maths NV
 Applied Maths NV Packaged SoftwareTechnology Services Applied Maths NV develops software for the biosciences. It offers desktop software such as BioNumerics, GelCompar II, GeneMaths XT, and Kodon. It also offers server software such as BioNumerics server. The firm also offers services such as training workshops, on-site training, data analysis, and scripts development. The company was founded by Paul Vauterin and Luc Vauterin in 1992 and is headquartered in Sint-Martens-Latem, Belgium. | Packaged Software | Chairman Director/Board Member | |
Alphamin SA
 Alphamin SA Industrial SpecialtiesProcess Industries Alphamin SA engages in the development and distribution of specialties. It offers bitumen modifiers, waxes, specialty polymers and adhesives, coatings and sealants. The firm also provides logistics and laboratory services. The company was founded by Bruce Philpott in 1991 and is headquartered in Wavre, Belgium. | Industrial Specialties | Director/Board Member Director/Board Member | |
| Université Catholique de Louvain | College/University | Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Hogeschool-Universiteit Brussel | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| University of Antwerp | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
Think2Act Partners BV
 Think2Act Partners BV Investment ManagersFinance Think2Act Partners BVBA (Think2Act Partners) is a private equity firm founded by Jo Breesch, Filip Lesaffer and Koen Verhelst in 2000. The firm headquartered in Zwijndrecht, Belgium. | Investment Managers | Founder Founder Founder | |
Planet-eco NV
 Planet-eco NV Wholesale DistributorsDistribution Services Planet-eco NV engages in retail of solar panels, sun boilers, and heat exchange pumps. It owns and operates ecological stores. The firm provides ecological products and services to save energy in homes and offices. The company was founded by Tom De Kegel, Koen Dehertog and Koen Heylen in 2008 and is headquartered in Ninove, Belgium. | Wholesale Distributors | Director/Board Member Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
KeBeK Management NV
 KeBeK Management NV Investment ManagersFinance KeBeK Management NV (KeBeK) is an independent private equity firm headquartered in Grimbergen, Belgium. The firm was founded by Floris Vansina, Gert Van Huffel, Ast Verbiest, and Gerd Smeets in 2012. | Investment Managers | Founder Founder | |
| BIOTALYS NV | Chemicals: Agricultural | Director/Board Member Director/Board Member Director/Board Member | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| BIOCARTIS GROUP NV | Medical Specialties | Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer Director/Board Member | |
Biocartis NV
 Biocartis NV Internet Software/ServicesTechnology Services Part of Biocartis Group NV, Biocartis NV is a Belgian molecular diagnostics company that aims to revolutionize the field with its proprietary IdyllaTM platform. The company is based in Mechelen, Belgium, and the CEO of the company is Herman Verrelst. The company provides next-generation diagnostic solutions with a focus on improving clinical practice in oncology for the benefit of patients, clinicians, payers, and the healthcare industry. | Internet Software/Services | Director/Board Member Chief Executive Officer | |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| België | 42 |
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 3 |
| Nederland | 2 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 4 |
| Technology Services | 4 |
Operationeel
| Director/Board Member | 402 |
| Corporate Officer/Principal | 104 |
| Chairman | 60 |
| Chief Executive Officer | 58 |
| Independent Dir/Board Member | 49 |
Sterkste connecties
| Insiders | |
|---|---|
| Raj Bhikhu Parekh | 50 |
| Luc Boedt | 35 |
| Rudi Mariën | 31 |
| Patrick van Beneden | 28 |
| Leen van den Neste | 24 |
| Jim van Heusden | 22 |
| Staf van Reet | 22 |
| Marten Steen | 21 |
| Rudi Pauwels | 19 |
| Gil Beyen | 18 |
| Dirk JS Van den Berghen | 18 |
| Herman Verrelst | 16 |
| Thierry François | 16 |
| Chris de Jonghe | 15 |
| Domenico Valerio | 15 |
- Beurs
- Insiders
- Ruth Devenyns
- Bedrijfsconnecties
